
About Exsure Private Limited
Data last updated:
Exsure Private Limited is a private limited company based in Bhubaneswar, Odisha, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 18 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24239OR2021PTC038222.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹64,900. It is led by directors Abhishek Dutta and Swastika Paul.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Room No.301 Kiit Tbi Campus – 11 Kiit Univeristy Patia, Bhubaneswar, Odisha, India – 751024.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.44 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net loss of ₹14.24 Lakh (net margin -191.4%) and EBITDA of -₹13.75 Lakh (EBITDA margin -184.8%).
The company is associated with 1 brand: Exsure. The company has 1 deal on record (1 funding round), with disclosed funding of ₹3 Cr; the latest was in January 2025. Its 3 peer companies in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development) are compared by revenue, 1 larger and 2 smaller; the largest is Chrogene Aarogyam Biotech Private Limited with revenue of ₹8.07 Lakh.
For more details, the company can be reached via its website exsure.in.
Company details
Recognitions & Rankings of Exsure
Contact details
Exsure Private Limited's registered office is in Bhubaneswar, Odisha.
- Registered AddressRoom No.301 Kiit Tbi Campus – 11 Kiit Univeristy Patia, Bhubaneswar, Odisha, India – 751024
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Exsure is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Exsure Private Limited, buy the company report.
Financials of Exsure Private Limited
FY 2025 filings availableExsure Private Limited reported revenue of ₹7.44 Lakh (down 74% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 74% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹13.75 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹14.24 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -184.8% | |||
| Net Profit Margin | -191.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Exsure Private Limited, buy the company report.
Board of directors of Exsure Private Limited
Exsure has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Dutta | Director | 18 Nov 2021 | 5 Years 0 Months | Current |
| Swastika Paul | Director | 18 Nov 2021 | 5 Years 0 Months | Current |
Peer comparison
Exsure Private Limited is compared with the 3 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chrogene Aarogyam Biotech Private Limited | ₹8.07 Lakh (FY 2024) | 572.0% | Hyderabad, Telangana, India | |||
| Exsure Private Limitedthis company | ₹7.44 Lakh (FY 2025) | -₹14.24 Lakh | -191.4% | -74.0% | Bhubaneswar, Odisha, India | |
| Molecular Bios Private Limited | ₹7.39 Lakh (FY 2023) | 25.0% | Thiruvananthapuram, Kerala, India | |||
| Zygene Biotechnologies Private Limited | ₹7.33 Lakh (FY 2024) | 51.0% | Kanayannur, Kerala, India |
To see the full peer comparison of Exsure Private Limited, buy the company report.
Deals & funding
Exsure Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹3 Cr; the latest was in January 2025.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2025 | Funding round · Seed | ₹3 Cr | Investors: Unicorn India Ventures |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Exsure Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Exsure Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Exsure Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Exsure Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Abhishek Dutta was appointed as Director on 18 Nov 2021.
Frequently asked questions
Exsure is an active private limited company based in Bhubaneswar, Odisha, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 18 November 2021 (5+ years old) and is registered under CIN U24239OR2021PTC038222.
Exsure has 2 current directors:
- Abhishek Dutta - Director
- Swastika Paul - Director
The latest financial statements of Exsure on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Exsure is U24239OR2021PTC038222. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Exsure was incorporated on 18 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Cuttack.
Exsure has 1 deal on record (1 funding round), with disclosed funding of ₹3 Cr; the latest was in January 2025.
The peers of Exsure by revenue are Chrogene Aarogyam Biotech Private Limited, Molecular Bios Private Limited, Zygene Biotechnologies Private Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (scientific research and development).
Abhishek Dutta was appointed as Director on 18 Nov 2021. Swastika Paul was appointed as Director on 18 Nov 2021.
Yes, Exsure is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Exsure can be reached through the website exsure.in. Its registered office is in Bhubaneswar, Odisha, India.
The registered office of Exsure is at Room No.301 Kiit Tbi Campus – 11 Kiit Univeristy Patia, Bhubaneswar, Odisha, India – 751024.

